Nong Xu

机构：Dalhousie University, Nova Scotia Health Authority · ORCID：0000-0001-7499-0383

发表论文 125 篇 · 总被引 2167 次 · h-index 21

代表论文

• Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial (2024 · Nature Medicine · 被引 45)
• PARP (Poly ADP‐ribose Polymerase) Family in Health and Disease (2025 · MedComm · 被引 18)
• Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study (2025 · Journal of Clinical Oncology · 被引 18)
• Peroxymonosulfate enhanced photocatalytic degradation of organic dye by metal-free TpTt-COF under visible light irradiation (2024 · Scientific Reports · 被引 18)
• Pervaporation Dehydration Mechanism and Performance of High-Aluminum ZSM-5 Zeolite Membranes for Organic Solvents (2024 · International Journal of Molecular Sciences · 被引 15)
• First-line osemitamab (TST001) plus nivolumab and CAPOX for advanced G/GEJ cancer (TranStar102): Updated results of cohort G from a phase I/IIa study. (2025 · Journal of Clinical Oncology · 被引 10)